ROWLAND LLOYD A 4
4 · CytomX Therapeutics, Inc. · Filed Aug 12, 2022
Insider Transaction Report
Form 4
ROWLAND LLOYD A
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2022-08-10+135,000→ 135,000 totalExercise: $1.59Exp: 2032-08-09→ Common Stock (135,000 underlying) - Award
Performance Stock Units (PSUs)
2022-08-10+22,500→ 22,500 total→ Common Stock (22,500 underlying)
Footnotes (2)
- [F1]1/36th of the shares subject to the option vest on each monthly anniversary measured from August 10, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.
- [F2]Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone by 12/31/2023 and 50% of the PSUs vest upon achievement of a certain performance-based milestone by 12/31/2024.